131 related articles for article (PubMed ID: 9764478)
1. Synthesis and aldose reductase inhibitory activity of benzoyl-amino acid derivatives.
Benvenuti S; Severi F; Costantino L; Vampa G; Melegari M
Farmaco; 1998 Jun; 53(6):439-42. PubMed ID: 9764478
[TBL] [Abstract][Full Text] [Related]
2. Discovery of new inhibitors of aldose reductase from molecular docking and database screening.
Rastelli G; Ferrari AM; Costantino L; Gamberini MC
Bioorg Med Chem; 2002 May; 10(5):1437-50. PubMed ID: 11886806
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and aldose reductase inhibitory activity of a new series of benz[h]cinnolinone derivatives.
Costantino L; Rastelli G; Cignarella G; Barlocco D
Farmaco; 2000 Aug; 55(8):544-52. PubMed ID: 11132732
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel benzoic acid derivatives with benzothiazolyl subunit and evaluation as aldose reductase inhibitors.
Rakowitz D; Hennig B; Nagano M; Steger S; Costantino L; Matuszczak B
Arch Pharm (Weinheim); 2005 Sep; 338(9):411-8. PubMed ID: 16143954
[TBL] [Abstract][Full Text] [Related]
5. Thienocinnolinone alkanoic acid derivatives as aldose reductase inhibitors.
Pau A; Asproni B; Murineddu G; Boatto G; Grella GE; Rakowitz D; Costantino L; Pinna GA
Med Chem; 2006 Jan; 2(1):39-45. PubMed ID: 16787354
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of chiral 2H-chromene-N-imidazolo-amino acid conjugates as aldose reductase inhibitors.
Gopinath G; Sankeshi V; Perugu S; Alaparthi MD; Bandaru S; Pasala VK; Chittineni PR; Krupadanam GLD; Sagurthi SR
Eur J Med Chem; 2016 Nov; 124():750-762. PubMed ID: 27639366
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory activity and mechanism of inhibition of the N-[[(4-benzoylamino)phenyl]sulfonyl]amino acid aldose reductase inhibitors.
DeRuiter J; Mayfield CA
Biochem Pharmacol; 1990 Nov; 40(10):2219-26. PubMed ID: 2123105
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors.
Maccari R; Ottanà R; Curinga C; Vigorita MG; Rakowitz D; Steindl T; Langer T
Bioorg Med Chem; 2005 Apr; 13(8):2809-23. PubMed ID: 15781392
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, activity, and molecular modeling of new 2, 4-dioxo-5-(naphthylmethylene)-3-thiazolidineacetic acids and 2-thioxo analogues as potent aldose reductase inhibitors.
Fresneau P; Cussac M; Morand JM; Szymonski B; Tranqui D; Leclerc G
J Med Chem; 1998 Nov; 41(24):4706-15. PubMed ID: 9822541
[TBL] [Abstract][Full Text] [Related]
10. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
Ibrar A; Tehseen Y; Khan I; Hameed A; Saeed A; Furtmann N; Bajorath J; Iqbal J
Bioorg Chem; 2016 Oct; 68():177-86. PubMed ID: 27544072
[TBL] [Abstract][Full Text] [Related]
11. On the synthesis of bioisosters of o-benzothiazolyloxybenzoic acids and evaluation as aldose reductase inhibitors.
Rakowitz D; Muigg P; Schröder N; Matuszczak B
Arch Pharm (Weinheim); 2005 Sep; 338(9):419-26. PubMed ID: 16143958
[TBL] [Abstract][Full Text] [Related]
12. 1-Benzopyran-4-one antioxidants as aldose reductase inhibitors.
Costantino L; Rastelli G; Gamberini MC; Vinson JA; Bose P; Iannone A; Staffieri M; Antolini L; Del Corso A; Mura U; Albasini A
J Med Chem; 1999 Jun; 42(11):1881-93. PubMed ID: 10354396
[TBL] [Abstract][Full Text] [Related]
13. Novel substituted N-benzyl(oxotriazinoindole) inhibitors of aldose reductase exploiting ALR2 unoccupied interactive pocket.
Hlaváč M; Kováčiková L; Šoltésová Prnová M; Addová G; Hanquet G; Štefek M; Boháč A
Bioorg Med Chem; 2021 Jan; 29():115885. PubMed ID: 33271452
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory effect of benzodiazepine derivatives on the bovine lens aldose reductase enzyme.
Evcimen ND; Pekiner B; Süzen S; Büyükbingöl E
Biochem Mol Biol Int; 1998 Jun; 45(2):381-7. PubMed ID: 9678260
[TBL] [Abstract][Full Text] [Related]
15. Benzisothiazole-1,1-dioxide alkanoic acid derivatives as inhibitors of rat lens aldose reductase.
Primofiore G; Da Settimo F; La Motta C; Simorini F; Minutolo A; Boldrini E
Farmaco; 1997 Oct; 52(10):583-8. PubMed ID: 9507669
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of 2-(arylamino)-4(3H)-quinazolinones as novel inhibitors of rat lens aldose reductase.
DeRuiter J; Brubaker AN; Millen J; Riley TN
J Med Chem; 1986 May; 29(5):627-9. PubMed ID: 3084783
[TBL] [Abstract][Full Text] [Related]
17. Highly selective aldose reductase inhibitors. II. Optimization of the aryl part of 3-(arylmethyl)-2,4,5-trioxoimidazolidine-1-acetic acids.
Kotani T; Ishii A; Nagaki Y; Toyomaki Y; Yago H; Suehiro S; Okukado N; Okamoto K
Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):297-304. PubMed ID: 9118444
[TBL] [Abstract][Full Text] [Related]
18. (4-Oxo-2-thioxothiazolidin-3-yl)acetic acids as potent and selective aldose reductase inhibitors.
Kucerova-Chlupacova M; Halakova D; Majekova M; Treml J; Stefek M; Soltesova Prnova M
Chem Biol Interact; 2020 Dec; 332():109286. PubMed ID: 33038328
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and activity of a new series of (Z)-3-phenyl-2-benzoylpropenoic acid derivatives as aldose reductase inhibitors.
Wang SJ; Yan JF; Hao D; Niu XW; Cheng MS
Molecules; 2007 Apr; 12(4):885-95. PubMed ID: 17851441
[TBL] [Abstract][Full Text] [Related]
20. N-substituted tetrahydro-2,4-dioxoquinazolin-1-yl acetic acids as aldose reductase inhibitors.
Rakowitz D; Gmeiner A; Matuszczak B
Pharmazie; 2007 Aug; 62(8):636-7. PubMed ID: 17867563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
